Musachio et al., 1992 - Google Patents
Vinylstannylated alkylating agents as prosthetic groups for radioiodination of small molecules: design, synthesis, and application to iodoallyl analogs of spiperone and …Musachio et al., 1992
- Document ID
- 2644653862203054143
- Author
- Musachio J
- Lever J
- Publication year
- Publication venue
- Bioconjugate chemistry
External Links
Snippet
Radioiodinated tracers have diverse applications in biomedical research, and there are a number of methods for incorporation of radioiodine into organic substrates (Seevers & Counsell, 1982; Coenen et al., 1983; Baldwin, 1986). Direct electrophilic radioiodination is …
- 150000003384 small molecules 0 title abstract description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Meltzer et al. | Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging | |
| Pomper et al. | 21-[18F] fluoro-16. alpha.-ethyl-19-norprogesterone. Synthesis and target tissue selective uptake of a progestin receptor-based radiotracer for positron emission tomography | |
| Musachio et al. | Vinylstannylated alkylating agents as prosthetic groups for radioiodination of small molecules: design, synthesis, and application to iodoallyl analogs of spiperone and diprenorphine | |
| US20090004106A1 (en) | Radioligands for the 5 -Ht1b Receptor | |
| Kiesewetter et al. | Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens | |
| Vanbrocklin et al. | Preparation and evaluation of 17-ethynyl-substituted 16α-[18F] fluoroestradiols: selective receptor-based PET imaging agents | |
| Suehiro et al. | Radiosynthesis and evaluation of N-(3-[18F] fluoropropyl) paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET | |
| US5208338A (en) | Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans | |
| Helfenbein et al. | PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter | |
| Saji et al. | Radioiodinated 2′-iodospiperone: a new radioligand for in vivo dopamine receptor study | |
| Swahn et al. | Synthesis of unlabelled, 3H‐and 125I‐labelled β‐CIT and its ϖ‐fluoroalkyl analogues β‐CIT‐FE and β‐CIT‐FP, including synthesis of precursors | |
| Musachio et al. | Synthesis of a radioiodinated analog of epibatidine:(±)‐exo‐2‐(2‐iodo‐5‐pyridyl)‐7‐azabicyclo [2.2. 1] heptane for in vitro and in vivo studies of nicotinic acetylcholine receptors | |
| Zhao et al. | VMAT2 imaging agent, D6-[18F] FP-(+)-DTBZ: improved radiosynthesis, purification by solid-phase extraction and characterization | |
| Hanson et al. | Synthesis and evaluation of (17α, 20E) 21-[125I] iodo-11-substituted-19-norpregna-1, 3, 5 (10), 20-tetraene-3, 17β-diols: the influence of 11-stereochemistry on tissue distribution of radioiodinated estrogens | |
| Li et al. | Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats | |
| Müller et al. | Preparation of a potential positron emission tomographic radioligand for the dopamine transporter | |
| Bonasera et al. | The synthesis of [26, 27-11C] dihydroxyvitamin D3, a tracer for positron emission tomography (PET) | |
| Musachio et al. | Radioiodination via vinylstannylated alkylating agents | |
| Foged et al. | 11C-and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET | |
| Bois et al. | Synthesis, radiolabeling and baboon SPECT imaging of 2β-carbomethoxy-3β-(3′-[123I] iodophenyl) tropane ([123I] YP256) as a serotonin transporter radiotracer | |
| CA1192185A (en) | Gamma-emitting receptor-binding quinuclidinyl benzilates; methods of preparation thereof and imaging and assay methods utilizing same | |
| Wei et al. | Iodination and radiolabeling of α-allocryptopine with iodine-125 | |
| Foged et al. | [11C] NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET | |
| Musachio | Novel radioiodinated neuroreceptor ligands | |
| SAJI et al. | Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution |